Professor Jan Nilsson’s research team at Lund University has received an additional DKK 1,000,000 funding from the Novo Nordisk Foundation for carrying out preclinical studies for Follicum’s diabetes project based on modified osteopontin-related peptides.

The sum of DKK 1 000 000 has been awarded for the project application entitled “Identification of osteopontin-related peptides stimulating insulin secretion”. This represents a follow-on grant from the estimated DKK 400,000 the group received in 2017. Follicum owns the right to the results generated in connection with the project.

”This additonal grant from the Novo Nordisk Foundation is further proof that they regard the project as highly promising. We are delighted to be part of this exciting diabetes project in collaboration with Lund University,” says Jan Alenfall, CEO, Follicum.